NGeneBio Co., Ltd. (KOSDAQ:354200)
2,040.00
-90.00 (-4.23%)
At close: Feb 20, 2026
15.45% (1Y)
| Market Cap | 52.10B +58.7% |
| Revenue (ttm) | 9.98B +61.7% |
| Net Income | -12.96B |
| EPS | -771.98 |
| Shares Out | 25.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 630,430 |
| Average Volume | 2,096,850 |
| Open | 2,130.00 |
| Previous Close | 2,130.00 |
| Day's Range | 1,990.00 - 2,165.00 |
| 52-Week Range | 1,325.00 - 2,765.00 |
| Beta | 1.34 |
| RSI | 50.01 |
| Earnings Date | Mar 20, 2026 |